PROKIDNEY
ProKidney offers treatment of chronic kidney disease (CKD) through innovations in cellular therapy. ProKidney’s lead product candidate, REACT™ (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT™ has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting its ongoing Phase 3 clinical program.
PROKIDNEY
Industry:
Health Care Therapeutics
Founded:
2015-01-01
Address:
Salem, Oregon, United States
Country:
United States
Website Url:
http://www.prokidney.com
Total Employee:
101+
Status:
Active
Total Funding:
345 M USD
Technology used in webpage:
Google Maps Google Akamai Hosted
Similar Organizations
KfH
KfH offers comprehensive treatment for chronic kidney disease patients.
Renal Research Institute
The Renal Research Institute provides treatment for chronic kidney disease (CKD).
Current Advisors List
Current Employees Featured
Stock Details
Investors List
Suvretta Capital Management
Suvretta Capital Management investment in Post-IPO Equity - Prokidney
Social Capital
Social Capital investment in Post-IPO Equity - Prokidney
Key Employee Changes
Official Site Inspections
http://www.prokidney.com Semrush global rank: 6.94 M Semrush visits lastest month: 973
- Host name: 162.138.209.35.bc.googleusercontent.com
- IP address: 35.209.138.162
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Prokidney"
ProKidney Corp. - The Org
ProKidney (Nasdaq: PROK), a pioneer in the treatment of CKD through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney’s lead product candidate, REACT™ (Renal Autologous Cell …See details»
Prokidney - Crunchbase Company Profile & Funding
Where is Prokidney's headquarters? Prokidney is located in Salem, Oregon, United States. Who invested in Prokidney? Prokidney has 2 investors …See details»
ProKidney Corp. Completes Domestication from the Cayman
Jul 1, 2025 ProKidney’s lead product candidate, rilparencel (also known as REACT ®), is a first-in-class, patented, proprietary autologous cellular therapy being evaluated in Phase 2 and …See details»
Investor Relations | ProKidney
Jan 15, 2025 The Investor Relations website contains information about ProKidney's business for stockholders, potential investors, and financial analysts.See details»
ProKidney Company Profile - Office Locations, Competitors ... - Craft
See insights on ProKidney including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
ProKidney - Pioneers in the Treatment of Chronic …
Jul 8, 2025 ProKidney is a pioneer in the treatment of CKD. While current treatments can slow the progression of CKD to End Stage Kidney Disease (ESKD), there is no cure for CKD. ProKidney is at the forefront in the field of …See details»
About - Hope For CKD by ProKidney
ProKidney is currently evaluating rilparencel in the Phase 3 PROACT 1 clinical trial for the treatment of patients with Stages 3b and 4 CKD and type 2 diabetes. This trial is planned to be conducted at approximately 80 clinical sites in the …See details»
ProKidney - Pioneers in the Treatment of Chronic …
Continued innovation in the CKD treatment landscape through partnership At ProKidney, we believe in the value of working together to amplify our collective capabilities and make a bigger impact on patient lives.See details»
SEC Filing | ProKidney
Additionally, there are differences between the Proposed Organization Documents of ProKidney Delaware and the Existing Organizational Documents of ProKidney. of common stock and …See details»
Executive Team - ProKidney
The ProKidney team averages more than twenty years of experience, with over 150 years cumulative experience in the discovery, development, manufacturing and …See details»
ProKidney Corp. Completes Domestication from Cayman Islands …
Jul 1, 2025 ProKidney Corp. has completed its domestication to Delaware, with shares converting and trading resuming on July 2, 2025.See details»
ProKidney Corp. Completes Domestication from the Cayman …
WINSTON-SALEM, N.C., July 01, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics …See details»
Board of Directors - ProKidney
Mr. Legorreta is the founder and Chairman of Alianza Médica para la Salud, a non-profit organization dedicated to enhancing the quality of health care in Latin America by providing …See details»
Patient Advisory Board - ProKidney
At ProKidney, we believe that the most effective clinical trials are those that focus on the patient experience and are representative of the disease across all populations. Our Patient Advisory …See details»
SEC Filing | ProKidney
001-40560 ProKidney Corp. Cayman Islands 98-1586514 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 2000 Frontis Plaza Blvd., …See details»
ProKidney Just Set a New 52-Week High. Should You Buy, Sell, or …
5 days ago As ProKidney hits a fresh 52-week high, can it sustain momentum through late-stage trials, or should investors stay cautious amid the market’s mixed view?See details»
ProKidney Announces Key Leadership Appointments …
Mar 25, 2024 They bring critically important experience that strengthens our ability to execute on our late-stage clinical program and prepare the organization for future commercialization of …See details»
ProKidney Announces Strategic Updates to its Phase 3 Program to ...
Sep 3, 2024 Under Dr. Culleton’s leadership, ProKidney has made significant progress, including the implementation of improved quality management systems to ensure compliance with …See details»
ProKidney: Study 'Win' Send Shares Soaring >500% - Seeking Alpha
Jul 9, 2025 ProKidney shares surged 500% on positive Phase 2 CKD results. Read why I remain cautious about PROK stock despite the recent breakthrough.See details»
ProKidney Announces Alignment with the FDA on the Accelerated …
4 days ago ProKidney, a pioneer in the treatment of chronic kidney disease through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney’s lead product …See details»